Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations

BACKGROUND: We aimed to determine the association between beta-blocker or statin drug use and the future risk of symptomatic intracranial hemorrhage or persistent/progressive focal neurological deficit from cerebral cavernous malformations (CCM). METHODS: The population-based Scottish Audit of Intra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuurbier, Susanna M., Hickman, Charlotte R., Rinkel, Leon A., Berg, Rebecca, Sure, Ulrich, Al-Shahi Salman, Rustam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311291/
https://www.ncbi.nlm.nih.gov/pubmed/35410492
http://dx.doi.org/10.1161/STROKEAHA.121.037009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311291/
https://www.ncbi.nlm.nih.gov/pubmed/35410492
http://dx.doi.org/10.1161/STROKEAHA.121.037009

Ejemplares similares